Recon: DoJ subpoenas BioMarin over sponsored testing programs; Boehringer, Zealand’s weight loss drug shows promise in mid-stage MASH study
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsUnited States